Open Peer Review Reports for: Concept and design of a nationwide prospective feasibility/efficacy/safety study of weekly paclitaxel for patients with pathologically confirmed anaplastic thyroid cancer (ATCCJ-PTX-P2)
Pre-publication versions of this article are available by contacting info@biomedcentral.com.
| Original Submission | ||
|---|---|---|
| 24 Apr 2014 | Submitted | Original manuscript |
| Author responded | Author comments | |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| Author responded | Author comments | |
| Reviewed | Reviewer Report | |
| Reviewed | Reviewer Report | |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| Reviewed | Reviewer Report | |
| Resubmission - Version 4 | ||
| Submitted | Manuscript version 4 | |
| Publishing | ||
| 15 Jun 2015 | Editorially accepted | |
| 20 Jun 2015 | Article published | 10.1186/s12885-015-1490-8 |
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.
You can find further information about the peer review system here.
